Analgesic effects of intrathecal neostigmine.
Poddar
R K
RK
Gosavi
C P
CP
D000698:Analgesia / Q000379:methods*; D019162:Anesthetics, Combined / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000627:therapeutic use; D002045:Bupivacaine / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004357:Drug Synergism; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D007278:Injections, Spinal; D035002:Lower Extremity / Q000601:surgery; D009068:Movement / Q000187:drug effects; D009325:Nausea / Q000139:chemically induced* / Q000188:drug therapy; D009388:Neostigmine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012677:Sensation / Q000187:drug effects; D013997:Time Factors; D016896:Treatment Outcome
D019162:Anesthetics, Combined; D000779:Anesthetics, Local; D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D005947:Glucose; D002045:Bupivacaine